<html>
<head>
<title>Utah Legislature HB0066</title>
</head>
<body>
<div id="content">
<font face="Arial">
</font><font face="Arial" size="3">1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<center><b>OPIATE OVERDOSE RESPONSE ACT AMENDMENTS</b></font><font face="Arial" size="2"></center><br/>2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<center>2017 GENERAL SESSION</center><br/>3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<center>STATE OF UTAH</center><br/>4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<center></font><font face="Arial" size="3"><b>Chief Sponsor:  Carol Spackman Moss</b></font><font face="Arial" size="2"></center><br/>5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<center></font><font face="Arial" size="3">Senate Sponsor:  </font><font face="Arial" size="2"></font><font face="Arial" size="3">____________</font><font face="Arial" size="2"></center><br/>6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <hr style="width:90%; padding: 0; border: none; border-top: thick double #333; color: #333; text-align: right" /><br/>7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>LONG TITLE</b><br/>8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>General Description:</b><br/>9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This bill clarifies civil liability in the Opiate Overdose Response Act.<br/>10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>Highlighted Provisions:</b><br/>11&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This bill:<br/>12&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9656;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;clarifies the persons who are not civilly liable when administering an opiate<br/>13&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;antagonist under certain circumstances; and<br/>14&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9656;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;makes technical changes.<br/>15&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>Money Appropriated in this Bill:</b><br/>16&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;None<br/>17&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>Other Special Clauses:</b><br/>18&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;None<br/>19&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>Utah Code Sections Affected:</b><br/>20&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;AMENDS:<br/>21&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<a href="#26-55-104">26-55-104</a></b>, as last amended by Laws of Utah 2016, Chapters 202, 207, 208 and last<br/>22&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;amended by Coordination Clause, Laws of Utah 2016, Chapter 202<br/>23&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <hr style="width:90%; padding: 0; border: none; border-top: thick double #333; color: #333; text-align: right" /><br/>24&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<i>Be it enacted by the Legislature of the state of Utah:</i><br/>25&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 1.  Section <b>26-55-104</b><a name="26-55-104"></a> is amended to read:<br/>26&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>26-55-104.</b>   <b>Prescribing, dispensing, and administering an opiate antagonist --</b><br/>27&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>Immunity from liability.</b><br/><hr>28&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) (a) (i)  For purposes of Subsection (1)(a)(ii), "a person other than a health care<br/>29&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;facility or health care provider" includes  the following, regardless of whether the person has<br/>30&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;received funds from the department through the Opiate Overdose Outreach Pilot Program<br/>31&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;created in Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=26-55-107&session=2017GS">26-55-107</a>: <br/>32&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A)  a person described in Subsections <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=26-55-107&session=2017GS">26-55-107</a>(1)(a)(i)(A) through (1)(a)(i)(F); or<br/>33&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B)  an organization<u>,</u> defined by department rule made under Subsection<br/>34&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=26-55-107&session=2017GS">26-55-107</a>(7)(e)<u>,</u> that is in a position to assist an individual who is at increased risk of<br/>35&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;experiencing an opiate-related drug overdose event.<br/>36&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)  Except as provided in Subsection (1)(b), [<strike>a person, including an overdose outreach</strike><br/>37&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strike>provider, but not including a health care facility or health care provider, that</strike>] <u>the following</u><br/>38&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>individuals are not liable for any civil damages for acts or omissions made as a result of</u><br/>39&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>administering an opiate antagonist when the individual</u> acts in good faith to administer [<strike>an</strike>] <u>the</u><br/>40&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;opiate antagonist to an individual whom the person believes to be experiencing an<br/>41&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;opiate-related drug overdose event [<strike>is not liable for any civil damages for acts or omissions</strike><br/>42&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strike>made as a result of administering the opiate antagonist.</strike>]<u>:</u><br/>43&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(A)  an overdose outreach provider; or</u><br/>44&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(B)  a person other than a health care facility or health care provider.</u><br/>45&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)  A health care provider:<br/>46&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)  [<strike>does</strike>] <u>is</u> not [<strike>have immunity</strike>] <u>immune</u> from liability under Subsection (1)(a) when<br/>47&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the health care provider is acting within the scope of the health care provider's responsibilities<br/>48&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;or duty of care; and<br/>49&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)  [<strike>does have immunity</strike>] <u>is immune</u> from liability under Subsection (1)(a) if the health<br/>50&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;care provider is under no legal duty to respond and otherwise complies with Subsection (1)(a).<br/>51&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)  Notwithstanding Sections <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-1-501&session=2017GS">58-1-501</a>, <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-17b-501&session=2017GS">58-17b-501</a>, and <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-17b-502&session=2017GS">58-17b-502</a>, a health care<br/>52&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;provider who is licensed to prescribe an opiate antagonist may prescribe, including by a<br/>53&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;standing prescription drug order issued in accordance with Subsection <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=26-55-105&session=2017GS">26-55-105</a>(2), or<br/>54&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;dispense an opiate antagonist:<br/>55&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) (i)  to an individual who is at increased risk of experiencing an opiate-related drug<br/>56&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;overdose event;<br/>57&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)  <u>for an individual described in Subsection (2)(a)(i),</u> to a family member [<strike>of</strike>], friend<br/>58&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<strike>of</strike>], or other person, including a person described in Subsections <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=26-55-107&session=2017GS">26-55-107</a>(1)(a)(i)(A)<br/><hr>59&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;through (1)(a)(i)(F), that is in a position to assist [<strike>an</strike>] <u>the</u> individual [<strike>who is at increased risk of</strike><br/>60&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strike>experiencing an opiate-related drug overdose event</strike>]; or<br/>61&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)  to an overdose outreach provider for:<br/>62&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A)  furnishing <u>the opiate antagonist</u> to an individual [<strike>who is at increased risk of</strike><br/>63&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strike>experiencing an opiate-related drug overdose event, or to a family member of, friend of, or</strike><br/>64&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strike>other individual who is in a position to assist an individual who is at increased risk of</strike><br/>65&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strike>experiencing an opiate-related drug overdose event</strike>] <u>described in Subsection (2)(a)(i) or (ii)</u>, as<br/>66&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;provided in Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=26-55-106&session=2017GS">26-55-106</a>; or<br/>67&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B)  administering to an individual experiencing an opiate-related drug overdose event;<br/>68&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)  without a prescriber-patient relationship; and<br/>69&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)  without liability for any civil damages for acts or omissions made as a result of<br/>70&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;prescribing or dispensing the opiate antagonist in good faith.<br/>71&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)  A health care provider who dispenses an opiate antagonist to an individual or an<br/>72&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;overdose outreach provider under Subsection (2)(a) shall provide education to the individual or<br/>73&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;overdose provider that includes written instruction on how to:<br/>74&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)  recognize an opiate-related drug overdose event; and<br/>75&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)  respond appropriately to an opiate-related drug overdose event, including how to:<br/>76&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)  administer an opiate antagonist; and<br/>77&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)  ensure that an individual to whom an opiate antagonist has been administered<br/>78&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;receives, as soon as possible, additional medical care and a medical evaluation.<br/><br/><hr style="width:90%; color: #333; text-align: right" /><br/><hr style="width:90%; color: #333; text-align: right" /><br/><br/><b>Legislative Review Note<br/>Office of Legislative Research and General Counsel</b>
</font>
</div>
</body>
</html>
